Description
Reg. No. G4374 (Act 36/1947)
An inactivated bacterial vaccine for the active immunisation against neonatal enterotoxicosis and neonatal enteritis in pigs.
INDICATIONS
Porcilis® ColiClos is used for the passive immunisation of progeny by active immunisation of sows and gilts to reduce mortality and clinical signs during the first days of life, caused by those Escherichia coli strains, which express the adhesins F4ab (K88ab), F4ac (K88ac), F5 (K99), F6 (987P) and/or produce LT and caused by Clostridium perfringens type C.
COMPOSITION
| Active ingredient | Quantity per 2 mℓ dose |
| E. coli components: | |
| F4ab fimbrial adhesin | ≥ 9,7 log2 Ab titre¹ |
| F4ac fimbrial adhesin | ≥ 7,8 log2 Ab titre¹ |
| F5 fimbrial adhesin | ≥ 7,4 log2 Ab titre¹ |
| F6 fimbrial adhesin | ≥ 7,6 log2 Ab titre¹ |
| LT toxoid | ≥ 12,0 log2 Ab titre¹ |
| C. perfringens component: | |
| Type C (strain 578) β-toxoid | ≥ 20 IU2 |
¹Mean Antibody titre (Ab) obtained after vaccination of mice with a 1/20 or 1/40 sow dose.
2 International units of beta antitoxin according to Ph. Eur.
Adjuvant per 2 mℓ dose: 150 mg dl-α-tocopheryl acetate.
